APSR2026-1026

 
Late-Breaking
Submitted
Poster Presentation
 
AP14-017
P36
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1234445-46904-APSR26_High prevalence TB in lung cancer patients_Siska_433887.pdf
Format: PDF Only
08. Lung Cancer
2

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Faidul Hidayati Siska Ginting * , Faculty of Medicine Universitas Sumatera Utara Department of Pulmonology and Respiratory Medicine Medan Indonesia
Noni Novisari Soeroso - , Faculty of Medicine Universitas Sumatera Utara Department of Pulmonology and Respiratory Medicine Medan Indonesia
 
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Faidul Hidayati Siska
Ginting
fhsiskaginting@gmail.com
+6285274440305
31-40
Indonesia
Original Research
High prevalence of pulmonary tuberculosis in lung cancer patients receiving platinum-based chemotherapy
Maximum 25 words
Abstract Content
Indonesia has a high burden of TB, while lung cancer is the leading cause of cancer-related deaths. Platinum-based chemotherapy can compromise immunity and trigger TB reactivation or infection. This study assessed the prevalence of pulmonary TB among lung cancer patients receiving platinum-based chemotherapy in Medan, the timing of TB diagnosis (before vs. after chemotherapy), and the proportion of clinically diagnosed vs. bacteriologically confirmed TB.
A retrospective review of medical records and rapid molecular testing of Mycobacterium tuberculosis data at Prof. Dr. Chairuddin P. Lubis Universitas Sumatera Utara Hospital and Adam Malik Hospital in Medan (Jan 2023–June 2025). The consecutive sample included 134 patients who received ≥2 cycles of platinum-based chemotherapy. Univariate analysis was performed (SPSS v29).
Of the 134 patients, 42 (31.3%) were diagnosed with pulmonary TB according to rapid molecular testing of Mycobacterium tuberculosis. Ten patients (23.8%) had a history of TB before 2 cycles of chemotherapy, while 32 (76.19%) were diagnosed with TB after 2 cycles of chemotherapy. The most common complaints were chronic cough and shortness of breath. Among the 42 TB cases, 8 (19.0%) were clinical TB and 34 (81.0%) were bacteriologically confirmed.
The prevalence of pulmonary TB is high (31.3%) among lung cancer patients receiving platinum-based chemotherapy in Medan, with the majority being bacteriologically confirmed (81.0%) and most diagnosed after chemotherapy (76.19%), indicating a risk of reactivation associated with chemotherapy-induced immunosuppression. Screening for active TB before chemotherapy and close monitoring in endemic areas are strongly recommended. Bacteriological confirmation is essential to distinguish between clinical and confirmed TB for optimal management.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Tuberculosis, Lung Cancer, Platinum-based chemotherapy
maximum 3 keywords and no abbreviations, separated by commas
Thanks to the supervisors and participants at Adam Malik Hospital and Universitas Sumatera Utara Hospital for their cooperation.
264